Literature DB >> 5790922

Defibrination syndrome in phlegmasia ceruleaolens.

G L Saha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5790922      PMCID: PMC2466739     

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY; E GENTON; J HIRSH; F BACHMANN
Journal:  J Lab Clin Med       Date:  1965-05

2.  PHLEGMASIA CERULEA DOLENS: A 10-YEAR REVIEW.

Authors:  J M STALLWORTH; G B BRADHAM; R R KLETKE; R G PRICE
Journal:  Ann Surg       Date:  1965-05       Impact factor: 12.969

3.  Phlegmasia cerulea dolens.

Authors:  J R MEEK; J J MAURER
Journal:  Am J Surg       Date:  1959-01       Impact factor: 2.565

4.  Massive venous thrombosis associated with incoagulability of the blood.

Authors:  N ROSENBERG; R J ZULLO
Journal:  AMA Arch Surg       Date:  1958-06

5.  The defibrination syndrome: clinical features and laboratory diagnosis.

Authors:  C Merskey; A J Johnson; G J Kleiner; H Wohl
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

6.  Phlegmasia cerulea dolens.

Authors:  N L Robles; B R Walske; W C Wilcox
Journal:  Am J Surg       Date:  1966-11       Impact factor: 2.565

Review 7.  Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies).

Authors:  F Rodríguez-Erdmann
Journal:  N Engl J Med       Date:  1965-12-16       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.